Literature DB >> 7712234

Predictors of HIV disease progression in women.

R A Clark1, S A Blakley, J Rice, W Brandon.   

Abstract

A retrospective cohort study was conducted to analyze variables predictive of acquired immunodeficiency syndrome (AIDS), as defined by the Centers for Disease Control (CDC) in 1987, and death in 224 women infected with the human immunodeficiency virus (HIV) who were evaluated through two HIV outpatient programs in New Orleans between January 1987 and December 1991 and followed through February 1993. Variables predictive of AIDS in a multivariate proportional hazards model were an entry CD4 cell count < 200/mm3 (adjusted RR 8.2, 95% CI 3.2, 20.9) and rapid CD4 cell count decline (adjusted RR 6.0, 95% CI 2.4, 15.5). A baseline AIDS diagnosis (by the CDC 1987 definition) was highly predictive of death (RR 36.3, 95% CI 15.7, 70.1). In multivariate analyses none of the relative risks for predictive variables remained significant if adjusted for a diagnosis of AIDS at entry. Although immunological parameters were predictive of early HIV disease progression, an AIDS diagnosis was the strongest prognostic indicator of death in a cohort of North American women.

Entities:  

Mesh:

Year:  1995        PMID: 7712234

Source DB:  PubMed          Journal:  J Acquir Immune Defic Syndr Hum Retrovirol        ISSN: 1077-9450


  7 in total

1.  Anthropometric indices as predictors of survival in AIDS adults. Aquitaine Cohort, France, 1985-1997. Groupe d'Epidémiologie Clinique du Sida en Aquitaine (GECSA).

Authors:  R Thiébaut ; D Malvy; C Marimoutou; F Davis
Journal:  Eur J Epidemiol       Date:  2000       Impact factor: 8.082

2.  Survival and progression of HIV disease in women attending GUM/HIV clinics in Britain and Ireland. Study Group for the MRC Collaborative Study of HIV Infection in Women.

Authors: 
Journal:  Sex Transm Infect       Date:  1999-08       Impact factor: 3.519

3.  Weight loss and body mass index as predictors of HIV disease progression to AIDS in adults. Aquitaine cohort, France, 1985-1997.

Authors:  E Malvy; R Thiébaut; C Marimoutou; F Dabis
Journal:  J Am Coll Nutr       Date:  2001-12       Impact factor: 3.169

Review 4.  Candida glabrata: review of epidemiology, pathogenesis, and clinical disease with comparison to C. albicans.

Authors:  P L Fidel; J A Vazquez; J D Sobel
Journal:  Clin Microbiol Rev       Date:  1999-01       Impact factor: 26.132

5.  Gender differences in mortality and CD4 count response among virally suppressed HIV-positive patients.

Authors:  Mhairi Maskew; Alana T Brennan; Daniel Westreich; Lynne McNamara; A Patrick MacPhail; Matthew P Fox
Journal:  J Womens Health (Larchmt)       Date:  2013-01-25       Impact factor: 2.681

6.  Transcriptomic analysis of vulvovaginal candidiasis identifies a role for the NLRP3 inflammasome.

Authors:  Vincent M Bruno; Amol C Shetty; Junko Yano; Paul L Fidel; Mairi C Noverr; Brian M Peters
Journal:  MBio       Date:  2015-04-21       Impact factor: 7.867

7.  Gender differences in HIV disease progression and treatment outcomes among HIV patients one year after starting antiretroviral treatment (ART) in Dar es Salaam, Tanzania.

Authors:  Fausta Mosha; Victor Muchunguzi; Mecey Matee; Raphael Z Sangeda; Jurgen Vercauteren; Peter Nsubuga; Eligius Lyamuya; Anne-Mieke Vandamme
Journal:  BMC Public Health       Date:  2013-01-15       Impact factor: 3.295

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.